{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:54:58Z","timestamp":1791453298871,"version":"4.3.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the outcomes of trabeculectomy in the eyes with neovascular glaucoma (NVG), caused by proliferative diabetic retinopathy (PDR), central retinal vein occlusion (CRVO), and ocular ischemic syndrome (OIS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective review of NVG eyes that underwent trabeculectomy between 1991 and 2019. Complete success was defined as intraocular pressure (IOP) between 6 and 21 mmHg without antiglaucoma medications (AGM). The risk factors were analyzed by Cox\u2019s proportional hazard model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study included 100 eyes of 100 subjects with a mean age of 58 \u00b1 9.8 years and a median follow-up of 1.27 years (interquartile range: 0.63, 2.27). The cause of NVG was PDR in 59 eyes (59%), CRVO in 25 eyes (25%), and OIS in 16 eyes (16%). Trabeculectomy with mitomycin-C was performed in 88 eyes and trabeculectomy in 12 eyes. The cumulative complete success probability of trabeculectomy in PDR was 50% (95% confidence interval [CI]: 38, 65) at 1 year, 8% (1, 46) at 3\u20135 years. In OIS, it was 64% (43, 96) from 1 to 5 years. In CRVO, it was 75% (59, 94) at 1 year, 45% (23, 86) from 2 to 5 years. The PDR was associated with a higher risk of surgical failure compared to OIS (P = 0.04) and CRVO (P = 0.004). Other significant risk factors were increasing age (P = 0.02), persistent neovascularization of iris (NVI) (P = 0.03), higher number of anti-vascular endothelial growth factor (VEGF) injections prior to trabeculectomy (P = 0.02), and delay in performing trabeculectomy (P = 0.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Compared to CRVO and OIS, the eyes with NVG secondary to PDR had poor success with trabeculectomy. Older age, persistent NVI, need for a higher number of anti-VEGF injections, and delayed surgery were associated with a higher risk for trabeculectomy failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1516_21","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:37:01Z","timestamp":1636634221000},"page":"3341-3348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure"],"prefix":"10.4103","volume":"69","author":[{"given":"Sirisha","family":"Senthil","sequence":"first","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghava","family":"Chary","sequence":"additional","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hasnat","family":"Ali","sequence":"additional","affiliation":[{"name":"Center for Biostatistcs and Epidemiology, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhansi R","family":"Cherukuri","sequence":"additional","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja K","family":"Rani","sequence":"additional","affiliation":[{"name":"Srimati Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Choudhari","sequence":"additional","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Garudadri","sequence":"additional","affiliation":[{"name":"VST Center for Glaucoma Care, L. V. Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","article-title":"Neovascular glaucoma","volume":"26","author":"Hayreh","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"B2-20240828","article-title":"Neovascular glaucoma:Etiology, diagnosis and prognosis","author":"Shazly","year":"2009","journal-title":"A paper presented in the Seminars in Ophthalmology"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archopht.1991.01080030041034","article-title":"A prospective study of acute central retinal artery obstruction:The incidence of secondary ocular neovascularization","volume":"109","author":"Duker","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"RA138","DOI":"10.12659\/MSM.883260","article-title":"Ocular ischemic syndrome\u2013A systematic review","volume":"18","author":"Terelak-Borys","year":"2012","journal-title":"Med Sci Monit"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"2606147","DOI":"10.1155\/2018\/2606147","article-title":"Clinical analysis of 42 cases of ocular ischemic syndrome","volume":"2018","author":"Luo","year":"2018","journal-title":"J Ophthalmol"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5005\/jp-journals-10008-1062","article-title":"Management of neovascular glaucoma","volume":"3","author":"Dubey","year":"2009","journal-title":"J Curr Glaucoma Pract"},{"key":"B7-20240828","article-title":"Recent advances in the management of neovascular glaucoma","author":"SooHoo","year":"2013","journal-title":"A paper presented in the Seminars in Ophthalmology"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajo.2008.11.015","article-title":"Trabeculectomy with mitomycin-C for neovascular glaucoma:Prognostic factors for surgical failure","volume":"147","author":"Takihara","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0161-6420(93)31557-5","article-title":"Motteno tube implantation for neovascular glaucoma:Long-term results and factors influencing the outcome","volume":"100","author":"Mermoud","year":"1993","journal-title":"Ophthalmology"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10792-021-01789-y","article-title":"Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential?","volume":"41","author":"Rani","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"e0135766","DOI":"10.1371\/journal.pone.0135766","article-title":"Long-term outcomes and prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma","volume":"10","author":"Higashide","year":"2015","journal-title":"PLoS One"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma:A review","volume":"2","author":"Rodrigues","year":"2016","journal-title":"Int J Retin Vit"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","article-title":"Anti-VEGF therapy for glaucoma","volume":"21","author":"Horsley","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bjo.83.7.814","article-title":"Risk factors for failures of trabeculectomies performed without antimetabolites","volume":"83","author":"Mietz","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","article-title":"Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma","volume":"88","author":"Saito","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/IJG.0b013e3181d9ce12","article-title":"Combined intravitreal bevacizumab and trabeculectomy with mitomycin-C versus trabeculectomy with mitomycin-C alone for neovascular glaucoma","volume":"20","author":"Takihara","year":"2011","journal-title":"J Glaucoma"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2415-14-55","article-title":"Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma:A retrospective analysis","volume":"14","author":"Nakatake","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3341\/kjo.2001.15.2.98","article-title":"Midd-term effects of trabeculectomy with mitomycin-C in neovascular glaucoma patients","volume":"15","author":"Hyung","year":"2001","journal-title":"Korean J Ophthalmol"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/ijo.IJO_1591_20","article-title":"Neovascular glaucoma-A review","volume":"69","author":"Senthil","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1755-3768.1971.tb00954.x","article-title":"The frequency of rubeosis iridis in diabetic patients","volume":"49","author":"Ohrt","year":"1971","journal-title":"Acta Ophthalmol(Copenh)"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/112067210801800516","article-title":"Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin-C for neovascular glaucoma","volume":"18","author":"Al Obeidan","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/IJG.0b013e3181ccb794","article-title":"Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin-C","volume":"19","author":"Alkawas","year":"2010","journal-title":"J Glaucoma"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3182946398","article-title":"Intracameral ranibizumab and subsequent mitomycin-C augmented trabeculectomy in neovascular glaucoma","volume":"23","author":"Elmekawey","year":"2014","journal-title":"J Glaucoma"},{"key":"B24-20240828","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00150974","article-title":"The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment","volume":"15","author":"Sivalingam","year":"1991","journal-title":"Int Ophthalmol"},{"key":"B25-20240828","first-page":"250","article-title":"The Molteno implant in intractable glaucoma","volume":"2","author":"Downes","year":"1988","journal-title":"Ey|ne"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000095865","article-title":"Trabeculectomy with mitomycin-C for treatment of neovascular glaucoma in diabetic patients","volume":"220","author":"Kiuchi","year":"2006","journal-title":"Ophthalmologica"},{"key":"B27-20240828","first-page":"281","article-title":"Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma","volume":"5","author":"Shen","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12886-016-0248-7","article-title":"Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma:Assessment of efficacy and complications","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"774","DOI":"10.5301\/ejo.5000973","article-title":"Ahmed valves vs trabeculectomy combined with pans plana vitrectomy for neovascular glaucoma with vitreous hemorrhage","volume":"27","author":"Wang","year":"2017","journal-title":"Eur J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1516_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:35Z","timestamp":1787166815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1516_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1516_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"2021-06-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}